共 35 条
[1]
Ng ACT(2020)Leaflet immobility and thrombosis in transcatheter aortic valve replacement Eur Heart J 41 3184-3197
[2]
Holmes DR(2018)The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prosthesis Cathet Cardiovasc Interv 92 1414-1416
[3]
Mack MJ(2020)CHOICE Investigators. 5-Year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial JACC Cardiovasc Interv 13 1071-1082
[4]
Rashid HN(2020)Randomised comparison of a balloon-expandable and self-expandable valve with quantitative assessment of aortic regurgitation using magnetic resonance imaging Neth Heart J 28 253-265
[5]
Nasis AM(2019)Reprise III. Investigators two-year outcomes after transcatheter aortic valve replacement with mechanical vs self-expanding valves: the REPRISE III randomized clinical trial JAMA Cardiol 4 223-229
[6]
Gooley RP(2019)SCOPE I investigators. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial Lancet 394 1619-1628
[7]
Cameron JD(2020)Comparison of newer generation self-expandable vs balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial Eur Heart J 41 1890-1899
[8]
Browon AK(2017)The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus Circulation 136 1598-1609
[9]
Abdel-Wahab M(2015)The porcine valve type predicts obstructive thrombosis beyond the first three postoperative months in bioprosthesis in the aortic position Int J Cardiol 199 90-95
[10]
Landt M(2020)GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement N Engl J Med 382 120-129